Cystic fibrosis drug works in early trials; Century-old drug may slow Alzheimer's, Parkinson's;

> It appears that an experimental drug blocking the genetic flaw responsible for a form of cystic fibrosis has worked well in an early trial by Israeli researchers. Article

> A new study conducted by researchers at Children's Hospital & Research Center Oakland shows that a century-old drug, methylene blue, may be able to slow or even cure both Alzheimer's and Parkinson's disease. FierceBioResearcher

> Scientists have identified the antibodies that still circulate in the blood of survivors of the deadly 1918 flu outbreak and found that they still proved to be a potent antidote to the disease. FierceVaccines

> A new study in the New England Journal of Medicine questions the cost-effectiveness of Gardasil in older women, saying that the payback is reduced by their increased exposure to the virus that causes cervical cancer. FierceVaccines

And Finally... A sheriff gets locked in a prison cell--on purpose. Article

Suggested Articles

The profit margins and management of Community Health Group raise questions about oversight of managed care insurers.

Financial experts are warning practices about the pitfalls of promoting medical credit cards to their patients.

A proposed rule issued by HHS on Tuesday would expand short-term coverage, a move Seema Verma said will have "virtually no impact" on ACA premiums.